Friday 6 November 2026
Export RCEL’s income statement to Excel — free account
Avita Medical Inc.
RCEL Healthcare Medical Devices
Avita Medical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71.6 million, up 11.5% from fiscal 2024.
- Revenue
- +53.1%
- EPS
- +56.9%
- Free cash flow
- +86.7%
- Total debt
- +7.13%
Quarter to September 2026, against a year earlier
16.56
0.88
+5.61%
Follow RCEL
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 3 | 3 | 3 |
+8 more TTM periods Free account |
| 191.59% | 211.55% | 326.92% | 799.72% | ||
| (65.36%) | (81.36%) | (74.88%) | (71.40%) | ||
ROIC |
0.00% | (306.20%) | (288.05%) | (334.18%) | |
Return on Tangible Assets |
(301.13%) | 131.98% | 169.09% | 261.83% | |
Average Days of Receivables |
44.58 | 47.62 | 49.87 | 46.31 | |
Free Cash Flow per Share |
(0.65) | (0.82) | (1.06) | (1.18) | |
Free Cash Flow |
(19.91) | (25.25) | (32.40) | (32.83) | |
Capital Expenditures |
(0.20) | (1.02) | (1.44) | (1.64) | |
| Other line items | |||||
Cash ROIC |
(79.85%) | (84.28%) | (87.01%) | (73.76%) | |
Accounts Receivable Turnover |
8.75 | 7.13 | 6.60 | 6.86 | |
Accounts Payable Turnover |
2.31 | 2.04 | 1.70 | 1.68 | |
Inventory Turnover |
2.48 | 2.18 | 1.86 | 1.80 | |
Average Days of Payables |
118.23 | 168.06 | 195.44 | 255.59 | |
Days of Inventory on Hand |
117.37 | 138.33 | 165.58 | 197.59 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
24.91% | 26.64% | 27.90% | 29.10% | |
Selling, General and Administrative Expense of Revenue |
91.34% | 101.48% | 108.07% | 112.43% | |
Share Based Compensation of Revenue |
7.24% | 9.57% | 10.96% | 13.29% | |
Interest Coverage |
(5.42) | (6.97) | (7.73) | (8.71) | |
Operating CF/Net income |
0.55 | 0.56 | 0.68 | 0.64 | |
Depreciation/Fixed assets |
0.34 | 0.33 | 0.30 | 0.27 | |
Capex/Depreciation |
(0.08) | (0.41) | (0.59) | (0.70) | |
Revenue per Share |
2.74 | 2.46 | 2.37 | 2.57 | |
Operating CF per Share |
(0.64) | (0.79) | (1.01) | (1.12) | |
Capex per Share |
(0.01) | (0.03) | (0.05) | (0.06) | |
Capex to Sales |
0.00 | 0.01 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026